Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1330 issues

Skyrizi (Risankizumab) Approval with Blue Cross Blue Shield in New Jersey: Complete Guide to Prior Authorization, Appeals, and Coverage

Quick Answer: Getting Skyrizi Covered by Blue Cross Blue Shield in New Jersey Horizon Blue Cross Blue Shield of New Jersey requires prior authorization for Skyrizi (risankizumab), a specialty medication. Start by having your prescriber submit a PA request through the Horizon provider portal within 72 hours for standard approval.

Work With Your Doctor to Get Epidiolex (Cannabidiol) Covered by Blue Cross Blue Shield in Virginia: Complete Provider Partnership Guide

Answer Box: Getting Epidiolex Covered by Blue Cross Blue Shield in Virginia Epidiolex (cannabidiol) requires prior authorization from Blue Cross Blue Shield in Virginia for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC). Your fastest path to approval: 1) Confirm your diagnosis and document failed

Do You Qualify for Waylivra (Volanesorsen) Coverage by Blue Cross Blue Shield in Virginia? Decision Tree & Next Steps

Answer Box: Your Path to Waylivra Coverage in Virginia Waylivra (volanesorsen) isn't FDA-approved, making Blue Cross Blue Shield coverage challenging but possible through medical necessity appeals. You'll need confirmed familial chylomicronemia syndrome (FCS) with genetic testing, fasting triglycerides ≥880 mg/dL despite standard therapy, and specialist

If Hemlibra Isn't Approved by Blue Cross Blue Shield in North Carolina: Formulary Alternatives & Exception Paths

Answer Box: When Hemlibra Isn't Your First Option If Blue Cross Blue Shield of North Carolina requires you to try other hemophilia A treatments before Hemlibra (emicizumab-kxwh), you'll typically start with factor VIII concentrates or extended half-life options. Most BCBS NC plans use step therapy, requiring

How to Get Pomalyst (pomalidomide) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pomalyst Covered by Blue Cross Blue Shield in New Jersey Pomalyst (pomalidomide) requires prior authorization from Blue Cross Blue Shield plans in New Jersey for multiple myeloma treatment. To get approved: (1) Ensure your oncologist documents prior lenalidomide and proteasome inhibitor failures with progression within 60 days,

Do You Qualify for Trikafta Coverage by Blue Cross Blue Shield in Virginia? Decision Tree & Next Steps

Quick Answer: Trikafta requires prior authorization from Blue Cross Blue Shield (BCBS) Virginia plans. You qualify if you have cystic fibrosis with at least one F508del mutation (or another responsive CFTR variant), are 2+ years old, and have proper genetic testing documentation. Submit via Availity's ICR tool or

How to Get Firazyr (Icatibant) Covered by Blue Cross Blue Shield in Florida: Complete Prior Authorization Guide

Quick Answer: Getting Firazyr Covered by Florida Blue Florida Blue (Blue Cross Blue Shield of Florida) requires prior authorization for Firazyr (icatibant) for acute HAE attacks. Submit PA via Availity.com or call 1-877-719-2583 with HAE diagnosis (ICD-10: D84.1), lab confirmation (low C4, abnormal C1-INH), and attack history. Initial

Work With Your Doctor to Get Rinvoq (Upadacitinib) Approved by Blue Cross Blue Shield in Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Rinvoq Approved by BCBS Illinois Rinvoq (upadacitinib) requires prior authorization from Blue Cross Blue Shield of Illinois with mandatory step therapy requiring failure of ≥1 TNF inhibitor first. Your fastest path: (1) Document TNF inhibitor failures with your rheumatologist/dermatologist, (2) Submit PA via CoverMyMeds with complete

How to Get Alecensa (alectinib) Covered by Blue Cross Blue Shield in Texas: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Alecensa Covered by Blue Cross Blue Shield in Texas Blue Cross Blue Shield of Texas typically requires prior authorization for Alecensa (alectinib) with ALK-positive NSCLC confirmation and may require step therapy with crizotinib first. Start by gathering your ALK testing results and staging documentation. Submit your prior

Get Arikayce Covered by Blue Cross Blue Shield in Pennsylvania: Forms, Appeals & State Resources

Answer Box: Getting Arikayce Covered in Pennsylvania Blue Cross Blue Shield plans in Pennsylvania require prior authorization for Arikayce (amikacin liposome inhalation), a specialty drug for refractory MAC lung disease. The fastest path to approval: 1) Verify your specific Blue Cross plan (Highmark or Independence), 2) Submit complete prior authorization